238 related articles for article (PubMed ID: 11023050)
1. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
2. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
Murakoshi M; Ikeda R; Fukui N
J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
[TBL] [Abstract][Full Text] [Related]
3. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Ikeda R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
Murakoshi M; Inada R; Tagawa M; Makino M; Suzuki M; Mieda M; Honma S; Takezawa Y; Yamanaka H
Acta Pathol Jpn; 1992 Mar; 42(3):151-7. PubMed ID: 1373927
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
Murakoshi M; Masuda S; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
Tokai J Exp Clin Med; 1998 Nov; 23(5):245-8. PubMed ID: 10418729
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
9. The effects of new steroidal anti-androgen, TZP-4238, and chlormadinone acetate on the pituitary, prostate and adrenal gland of the rat: histopathological and immunocytochemical studies.
Murakoshi M; Tagawa M; Inada R; Shoji M; Suzuki M; Watanabe K
Endocrinol Jpn; 1992 Aug; 39(4):331-40. PubMed ID: 1280213
[TBL] [Abstract][Full Text] [Related]
10. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Murakoshi M; Tagawa M; Ikeda R
J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
Ito K; Fukabori Y; Shibata Y; Suzuki K; Mieda M; Gotanda K; Honma S; Yamanaka H
Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
[TBL] [Abstract][Full Text] [Related]
12. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
13. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
[TBL] [Abstract][Full Text] [Related]
15. Effects of combination therapy with a luteinizing hormone-releasing hormone agonist and chlormadinone acetate on rat prostate weight and plasma testosterone levels.
Gotanda K; Shinbo A; Okada M; Nakano Y; Kobayashi H; Sasaki T; Hagiwara M; Akaza H
Prostate Cancer Prostatic Dis; 2003; 6(1):66-72. PubMed ID: 12664069
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Murakoshi M; Inada R; Makino M; Suzuki M; Mieda M; Honma S; Yamanaka H
Acta Pathol Jpn; 1990 Dec; 40(12):871-9. PubMed ID: 1710865
[TBL] [Abstract][Full Text] [Related]
18. Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Takezawa Y; Fukabori Y; Yamanaka H; Mieda M; Honma S; Kushitani M; Hamataki N
Prostate; 1992; 21(4):315-29. PubMed ID: 1281324
[TBL] [Abstract][Full Text] [Related]
19. [Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
Noguchi K; Uemura H; Takeda M; Sekiguchi Y; Ogawa K; Hosaka M
Hinyokika Kiyo; 2000 Sep; 46(9):605-7. PubMed ID: 11107528
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
